Clinical Trial Update: Efficacy and Performance Evaluation of mGlobal L+AS 20 mg/ml Hyaluronic Acid, for the Correction of Light to Moderate Wrinkles and Folds [NA]

View source ↗

Summary

Completed trial evaluating the efficacy and performance of mGlobal L+AS 20 mg/ml hyaluronic acid for correcting light to moderate facial wrinkles and folds.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Aging
• Skin Wrinkling

Drugs mentioned

• mGlobal L+AS 20 mg/ml Hyaluronic Acid (Hyaluronic acid)

Snippet

Sponsor: Mesoestetic Pharma Group S.L. | Conditions: Skin Aging, Skin Wrinkling | NA | Status: COMPLETED